BLOG/🇺🇸United States··daily

Global High-Priority Regulatory Events — February 08, 2026

Global High Priority Market Events

120 high priority120 total filings analysed

Executive Summary

Across 120 filings on February 9, 2026, a massive cluster of ~65 Item 5.02 disclosures for officer/director changes (avg materiality 4/10, neutral sentiment) across sectors like banking (e.g., FIRST BANCORP/PR, Glacier Bancorp), biotech (Ocugen, IN8BIO), and energy (EQT, EXPAND ENERGY) signals potential routine governance refreshes or hidden instability amid no disclosed quantitative impacts. ~35 high-materiality (avg 8/10) Item 1.01 material definitive agreements (e.g., ProCap Financial, Nauticus Robotics, AMC Entertainment) alongside ~10 acquisitions/dispositions (Item 2.01, e.g., Waters Corp, XOMA Royalty) indicate robust M&A/deal activity, though undisclosed terms limit assessment. Critical bearish outliers include 4 delisting notices (Generation Bio mixed/high risk 10/10, Curis/VolitionRx/374Water bearish/critical 10/10) and insolvencies/administrations (Future Enterprises x2, 6 Unknowns medium 6/10 bearish). Neutral sentiment dominates (95% of filings), with no period-over-period metrics, insider trades, guidance, or capital allocation data disclosed across the board; Indian filings (e.g., Nirbhay Colours open offers x2, Aadhar open offer) highlight takeover bids. Portfolio implications: active M&A flow bullish for deal arbitrage, but leadership churn and delistings warrant short-term caution; prioritize exhibit reviews for alpha.

Tracking the trend? Catch up on the prior Global High-Priority Regulatory Events digest from February 07, 2026.

Investment Signals(12)

  • Multi-item 8-K incl Item 1.01 material agreement + Item 2.01 acquisition completion + Item 3.02 equity sales (medium risk 8/10 materiality) signals strategic expansion despite dilution risk

  • Item 1.01 material agreement + Item 2.03 financial obligation + Item 3.02 equity dilution + Item 5.03 governance amendments (medium risk 8/10) potential funding catalyst

  • Item 1.01 material agreement + Item 2.01 acquisition completion + Item 2.03 obligation (medium risk 9/10 materiality, 3MB filing) accretive deal flow

  • Item 1.01 material agreement + Item 8.01 other events (medium risk 9/10 materiality) turnaround potential post-restructuring

  • Item 2.01 acquisition/disposition completion + Item 7.01 Reg FD (medium risk 8/10) portfolio optimization

  • Item 2.01 asset disposition completion + Item 7.01 Reg FD (medium risk 8/10) deleveraging move

  • Mixed sentiment high materiality 10/10 with Item 5.01 change in control + Item 2.01 asset completion offset by delisting risk

  • Curis Inc(BEARISH)

    Item 3.01 delisting notice (bearish critical risk 10/10 materiality) liquidity erosion imminent

  • Item 3.01 delisting/transfer notice (bearish critical risk 10/10) compliance failure signals distress

  • Item 3.01 delisting + Item 5.02 officer change (bearish high risk 9/10) dual governance/compliance crisis

  • Dual insolvency filings (medium risk 6/10 x2) restructuring uncertainty

  • Bearish administration entry under Corporations Act (10/10 materiality) + CIO retirement signals distress

Risk Flags(10)

  • Officer Change Cluster (65+ cos e.g., NXP, Phoenix Motor, EQT, Verizon)[HIGH RISK]

    Undisclosed names/positions/reasons across ~65 filings (avg low-med risk 3-5/10) potential governance instability wave

  • Item 3.02 unregistered equity + Item 3.03 security rights mods + Item 5.03 bylaws changes (med risk 8/10) dilution + control shift

  • Nature's Miracle[MEDIUM RISK]

    Item 3.02 equity sales + undisclosed Item 5.02 changes (med risk 6/10) dilution + leadership uncertainty

  • Generation Bio[CRITICAL RISK]

    Item 3.01 delisting + Item 1.02 agreement termination + Item 3.03 rights mods (high risk 10/10 mixed) public status loss

  • Curis Inc[CRITICAL RISK]

    Item 3.01 delisting notice alone (critical risk 10/10 bearish) exchange removal

  • 374Water Inc[HIGH RISK]

    Item 3.01 delisting + Item 1.01 undisclosed agreement + Item 5.02 changes (high risk 9/10 bearish) multi-front crisis

  • VolitionRx Ltd[CRITICAL RISK]

    Item 3.01 delisting/transfer (critical risk 10/10 bearish) liquidity/visibility drop

  • Medium risk 6/10 cluster signals sector distress patterns

  • Sherwin-Williams[MEDIUM RISK]

    Item 2.03 new financial obligation undisclosed terms (med risk 8/10) balance sheet deterioration potential

  • Adani Enterprises (#14)[MEDIUM RISK]

    Rights issue outcome disclosed sans quantum/pricing/record date (neutral med 6/10) dilution risk opacity

Opportunities(10)

Sector Themes(6)

  • Executive Turnover Surge(WATCH GOVERNANCE)

    ~65 filings (e.g., 28 Phoenix Motor to 119 GigCapital9) Item 5.02 undisclosed changes avg low materiality 4/10 across banks/biotech/energy/gold trusts; implies routine refresh but cluster raises instability flags for small/mid caps

  • M&A/Deal Flow Acceleration(BULLISH PIPELINE)

    35+ Item 1.01 material agreements (avg 8/10 mat, e.g., ProCap to Clear Channel) + 10 Item 2.01 acqs (Waters, Seaport); neutral sentiment suggests healthy activity despite opacity, alpha in exhibit dives

  • Delisting/Compliance Distress(BEARISH SMALL CAPS)

    4 critical bearish Item 3.01 (Generation Bio 10/10 mixed, Curis/Volition/374Water 10/10); small caps overrepresented, liquidity traps post-event

  • Dilution via Equity Sales(MIXED FUNDING)

    10+ Item 3.02 unregistered sales (e.g., Nauticus, Nature's Miracle, Liminatus) tied to deals; med-high risk avg 7/10, balance sheet fortification vs shareholder pain

  • Banking Leadership Shifts(NEUTRAL SECTOR ROTATION)

    10+ banks (FIRST BANCORP/PR #33, Commerce #62, Glacier #91, Regions #101 etc.) Item 5.02 low risk 3-5/10; potential rate environment response sans metrics

  • Biotech/Pharma Churn(HIGH VOLATILITY)

    15+ (Ocugen #38, Predictive Oncology #40, Trisalus #53, Entera Bio #50, Volition #114 delist); med risk 5/10 avg + delists signal funding squeezes

Watch List(8)

Filing Analyses(120)
UnknownOpen Offermateriality 6/10

09-02-2026

Nirbhay Colours India LimitedOpen Offermateriality 6/10

09-02-2026

UnknownAdministrationmateriality 6/10

09-02-2026

Nirbhay Colours India LimitedOpen Offermateriality 6/10

09-02-2026

UnknownRate Changemateriality 6/10

09-02-2026

UnknownRate Changemateriality 6/10

09-02-2026

Kalyan Jewellers India LimitedTrading Suspensionmateriality 6/10

09-02-2026

UnknownOpen Offermateriality 6/10

09-02-2026

UnknownInsolvencymateriality 6/10

09-02-2026

Future Enterprises LimitedInsolvencymateriality 6/10

09-02-2026

Future Enterprises LimitedInsolvencymateriality 6/10

09-02-2026

Tata Motors LimitedCompany Updatemateriality 6/10

09-02-2026

Aadhar Housing Finance LimitedOpen Offermateriality 6/10

09-02-2026

Adani Enterprises LimitedOthersneutralmateriality 6/10

09-02-2026

Adani Enterprises Limited announced the outcome of the Rights Issue Committee meeting held on Monday, February 9, 2026, as per BSE filing. No specific details on the rights issue such as quantum, pricing, record date, entitlement ratio, or fund utilization were disclosed. This informational disclosure provides no quantitative financial metrics or period-over-period comparisons.

  • ·Event pertains to Rights Issue Committee meeting outcome
  • ·Filing source: BSE
  • ·BSE scrip code: 512599
Adani Enterprises LimitedCompany Updatemateriality 6/10

09-02-2026

Quipt Home Medical Corp.10-Qmateriality 6/10

09-02-2026

Warner Music Group Corp.10-Qmateriality 6/10

09-02-2026

UnknownAdministrationmateriality 6/10

10-02-2026

Sri Lotus Developers and Realty LimitedIPO Listingmateriality 6/10

09-02-2026

NXP Semiconductors N.V.8-Kneutralmateriality 4/10

09-02-2026

NXP Semiconductors N.V. filed an 8-K on 2026-02-09 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or quantitative impacts are disclosed.

ProCap Financial, Inc.8-Kneutralmateriality 8/10

09-02-2026

ProCap Financial, Inc. filed an 8-K on 2026-02-09 disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.01 completion of an acquisition or disposition of assets. The filing also covers Item 3.02 unregistered sales of equity securities, Item 5.02 departure/election of directors or appointment of officers including compensatory arrangements, Item 7.01 Regulation FD disclosure, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No quantitative financial terms, parties involved, synergies, or performance metrics were detailed.

Unknown8-Kneutralmateriality 3/10

09-02-2026

The company filed an 8-K on February 9, 2026 (AccNo: 0001851048-26-000002), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). No specific details on the officer's name, title, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, or timing are provided in the filing summary. No quantitative financial metrics, performance comparisons, or other material impacts are mentioned.

Functional Brands Inc.8-Kneutralmateriality 8/10

09-02-2026

Functional Brands Inc. filed a Form 8-K on February 9, 2026 (AccNo: 0001213900-26-013392, Size: 221 KB), reporting entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details, transaction values, financial metrics, positive or negative impacts, or named entities are disclosed in the provided filing summary. This is a multi-item mandatory disclosure with no quantitative data available.

SKF India (Industrial) LimitedIPO Listingmateriality 6/10

09-02-2026

La Rosa Holdings Corp.8-Kneutralmateriality 8/10

09-02-2026

La Rosa Holdings Corp. filed a Form 8-K on 2026-02-09 reporting under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits (file size 4 MB). This is a multi-item filing with both mandatory (Item 1.01) and voluntary (Item 8.01) disclosures, filed on the event date suggesting timely compliance within the 4-business-day requirement. No specific details on the agreement, events, transaction value, financial impacts, or exhibits are disclosed in the provided information.

Nature's Miracle Holding Inc.8-Kneutralmateriality 6/10

09-02-2026

Nature's Miracle Holding Inc. filed a Form 8-K on 2026-02-09 disclosing entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), and departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements (Item 5.02), with financial statements and exhibits under Item 9.01. No quantitative financial impacts, transaction values, or specific details on the agreement, equity sales, or personnel changes are disclosed. This multi-item filing signals potential strategic shifts but lacks data to assess positive or negative effects.

UnknownInsolvencymateriality 6/10

09-02-2026

PHOENIX MOTOR INC.8-Kneutralmateriality 5/10

09-02-2026

PHOENIX MOTOR INC. filed an 8-K on 2026-02-09 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names of individuals, key positions affected (e.g., CEO, CFO), reasons for the change, timing, internal/external status, or any quantitative data are disclosed. Sector is not specified.

  • ·Event date: February 09, 2026
  • ·Filing AccNo: 0001493152-26-005679
  • ·File size: 197 KB
EDGEWELL PERSONAL CARE Co8-Kneutralmateriality 3/10

09-02-2026

EDGEWELL PERSONAL CARE Co filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), alongside results of operations and financial condition (Item 2.02), submission of matters to a vote of security holders (Item 5.07), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). No specific details on the officer involved, position affected, reason for change, timing, or any quantitative financial metrics are disclosed in the provided filing summary. No positive or negative performance metrics, comparisons, or governance implications are mentioned.

EQT Corp8-Kneutralmateriality 3/10

09-02-2026

EQT Corp filed an 8-K on 2026-02-09 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Specific details including names, titles, reasons for change, or effective dates are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other material impacts are mentioned.

Kyndryl Holdings, Inc.8-Kneutralmateriality 5/10

09-02-2026

Kyndryl Holdings, Inc. filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 7.01 (Regulation FD Disclosure). No specific details on the affected position, individual name, appointment or resignation status, reason for change, or timing are provided. No quantitative financial metrics, performance comparisons, or other numerical data are mentioned.

Advantage Solutions Inc.8-Kneutralmateriality 8/10

09-02-2026

Advantage Solutions Inc. filed a Form 8-K on February 9, 2026, disclosing entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This multi-item filing includes both mandatory (Item 1.01) and voluntary (Item 7.01) disclosures, but specific details on the agreement, events, or exhibits are NOT_DISCLOSED. No quantitative financial metrics, transaction values, or performance comparisons are provided.

FIRST BANCORP /PR/8-Kneutralmateriality 3/10

09-02-2026

FIRST BANCORP /PR/ filed an 8-K on 2026-02-09 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons, or timing were disclosed.

UnknownRate Changemateriality 6/10

09-02-2026

Belrise Industries LimitedIPO Listingmateriality 6/10

09-02-2026

Future Consumer LimitedFraud Investigationmateriality 6/10

09-02-2026

UnknownInsolvencymateriality 6/10

09-02-2026

Ocugen, Inc.8-Kneutralmateriality 3/10

09-02-2026

Ocugen, Inc. filed an 8-K on 2026-02-09 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are disclosed. No quantitative financial metrics, performance comparisons, or other numerical data are mentioned.

VERIZON COMMUNICATIONS INC8-Kneutralmateriality 3/10

09-02-2026

Verizon Communications Inc filed an 8-K on 2026-02-09 under Item 5.02 disclosing a matter related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including names, positions affected, reasons for change, or quantitative data are disclosed in the provided filing summary. No positive or negative metrics are mentioned.

Predictive Oncology Inc.8-Kneutralmateriality 5/10

09-02-2026

Predictive Oncology Inc. filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, or any governance implications are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or scheduled events are mentioned.

EXPAND ENERGY Corp8-Kneutralmateriality 5/10

09-02-2026

EXPAND ENERGY Corp filed an 8-K on 2026-02-09 disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details such as the key position affected (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, or any quantitative data like compensation amounts are disclosed. This appears to be a routine disclosure of leadership transition without further context provided.

UNIVERSAL CORP /VA/8-Kneutralmateriality 5/10

09-02-2026

Universal Corp /VA/ filed an 8-K on February 9, 2026 (AccNo: 0001628280-26-006200), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). Specific details on the officer change, including name, title, reason, or timing, are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events were mentioned.

PULTEGROUP INC/MI/8-Kneutralmateriality 4/10

09-02-2026

PulteGroup Inc/MI/ filed an 8-K on 2026-02-09 under Item 5.02 disclosing departure of directors or certain officers, election or appointment of directors or certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific names, positions, reasons, effective dates, or quantitative details were disclosed in the provided filing summary.

Nauticus Robotics, Inc.8-Kneutralmateriality 8/10

09-02-2026

Nauticus Robotics, Inc. filed a multi-item Form 8-K on February 9, 2026, disclosing entry into a material definitive agreement (Item 1.01), creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), unregistered sales of equity securities (Item 3.02), material modifications to rights of security holders (Item 3.03), amendments to articles of incorporation or bylaws (Item 5.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific transaction details, dollar values, share counts, or financial impacts are disclosed in the provided filing summary. This filing indicates multiple significant corporate actions but lacks quantitative data for balanced assessment of positive or negative effects.

AMC ENTERTAINMENT HOLDINGS, INC.8-Kneutralmateriality 9/10

09-02-2026

AMC Entertainment Holdings, Inc. filed a Form 8-K on February 9, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details on the agreement, events, transaction values, financial impacts, or quantitative metrics were provided in the filing summary. This is a multi-item informational filing with no disclosed positive or negative metrics.

LABCORP HOLDINGS INC.8-Kneutralmateriality 5/10

09-02-2026

Labcorp Holdings Inc. filed an 8-K on 2026-02-09 disclosing matters under Item 5.02 related to departure of directors or certain officers, election or appointment of directors or officers, and compensatory arrangements of certain officers. The filing also includes Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details on the officer involved, position affected, reason for change, timing, or any quantitative data are disclosed in the provided filing summary.

SHF Holdings, Inc.8-Kneutralmateriality 8/10

09-02-2026

SHF Holdings, Inc. filed an 8-K on February 9, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 7.01 a Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. No specific details, transaction values, financial metrics, positive or negative changes, or period-over-period comparisons are provided in the available information. This is a multi-item filing with no disclosed quantitative impacts.

IN8BIO, INC.8-Kneutralmateriality 5/10

09-02-2026

IN8BIO, INC. filed an 8-K on 2026-02-09 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, or timing are disclosed. No quantitative data, financial metrics, or other changes are mentioned.

  • ·AccNo: 0001193125-26-041975
  • ·File size: 140 KB
  • ·Event date: 2026-02-09
  • ·Sector: NOT_DISCLOSED
Workday, Inc.8-Kneutralmateriality 6/10

09-02-2026

Workday, Inc. filed a Form 8-K on 2026-02-09 disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD disclosure under Item 7.01 and references to financial statements and exhibits under Item 9.01. No specific details on the affected officer, position, reason for change, timing, or any quantitative data are disclosed.

Entera Bio Ltd.8-Kneutralmateriality 5/10

09-02-2026

Entera Bio Ltd. filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are provided in the available information. No quantitative financial metrics, performance comparisons, or governance impacts are mentioned.

Limitless X Holdings Inc.8-Kneutralmateriality 8/10

09-02-2026

Limitless X Holdings Inc. filed an 8-K on 2026-02-09 reporting entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or an obligation under an off-balance sheet arrangement under Item 2.03. Item 9.01 discloses financial statements and exhibits. No specific details on transaction terms, values, parties, or impacts are provided.

Adani Enterprises LimitedCorp. Actionmateriality 6/10

09-02-2026

TriSalus Life Sciences, Inc.8-Kneutralmateriality 5/10

09-02-2026

TriSalus Life Sciences, Inc. filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, and any compensatory arrangements are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other numerical data are provided in the filing summary.

UnknownMonetary Policymateriality 6/10

09-02-2026

UnknownInsolvencymateriality 6/10

09-02-2026

LVPAI GROUP Ltd8-Kneutralmateriality 7/10

09-02-2026

LVPAI GROUP Ltd filed an 8-K on 2026-02-09 reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No quantitative financial metrics, transaction details, period-over-period comparisons, or directional impacts are disclosed. This is a multi-item mandatory disclosure with no specified dollar values or strategic context provided.

SHERWIN WILLIAMS CO8-Kneutralmateriality 8/10

09-02-2026

Sherwin-Williams Co filed an 8-K on 2026-02-09 under Items 1.01, 2.03, and 9.01, disclosing entry into a material definitive agreement and creation of a direct financial obligation or off-balance sheet arrangement. No quantitative details such as transaction value, terms, or financial impacts are provided. This is a multi-item mandatory filing with exhibits attached under Item 9.01.

FIRST MERCHANTS CORP8-Kneutralmateriality 4/10

09-02-2026

FIRST MERCHANTS CORP filed an 8-K on 2026-02-09 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, names, reasons, timing, or financial impacts are disclosed.

World Gold Trust8-Kneutralmateriality 3/10

09-02-2026

World Gold Trust filed an 8-K on February 9, 2026 (AccNo: 0001437749-26-003438), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Specific details including key positions affected, individuals involved, reasons for change, or timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other material impacts are mentioned.

SPDR GOLD TRUST8-Kneutralmateriality 3/10

09-02-2026

SPDR GOLD TRUST filed an 8-K on 2026-02-09 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individual names, appointment or resignation status, reasons, or timing are disclosed. No financial metrics, quantitative changes, or other impacts are mentioned.

Northfield Bancorp, Inc.8-K/Aneutralmateriality 4/10

09-02-2026

Northfield Bancorp, Inc. filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons, timing, or quantitative data were provided.

COMMERCE BANCSHARES INC /MO/8-Kneutralmateriality 3/10

09-02-2026

Commerce Bancshares Inc./MO/ filed an 8-K on February 9, 2026 (AccNo: 0000022356-26-000058), disclosing an officer change under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details such as the affected key position, executive names, reason for change, timing, or any financial metrics are provided in the filing summary. This is a routine disclosure with no quantified positive or negative impacts mentioned.

  • ·Sector: not specified
  • ·Filing size: 160 KB
Unknown8-Kneutralmateriality 5/10

09-02-2026

The company filed an 8-K on February 9, 2026 (AccNo: 0001213900-26-013602), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer's position, name, reason for departure or appointment, timing, or compensatory arrangements are disclosed. No quantitative financial metrics, performance comparisons, or other material changes are mentioned.

Liminatus Pharma, Inc.8-Kneutralmateriality 8/10

09-02-2026

Liminatus Pharma, Inc. filed an 8-K on February 9, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 3.02 unregistered sales of equity securities, with Item 9.01 providing financial statements and exhibits. No specific details on the agreement, transaction size, financial impacts, or strategic rationale are provided in the filing summary. This is a multi-item mandatory disclosure with no quantitative metrics or period-over-period comparisons disclosed.

IMMUCELL CORP /DE/8-Kneutralmateriality 4/10

09-02-2026

Immucell Corp (/DE/) filed an 8-K on February 9, 2026 (AccNo: 0001437749-26-003514), disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected individuals, positions, reasons, timing, or financial impacts are disclosed.

FOX FACTORY HOLDING CORP8-Kneutralmateriality 6/10

09-02-2026

Fox Factory Holding Corp filed a Form 8-K on February 9, 2026 (AccNo: 0001424929-26-000002, Size: 408 KB), reporting under Item 1.01 entry into a material definitive agreement, under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. This is a multi-item mandatory filing with no quantitative financial metrics, transaction values, dollar amounts, share counts, percentages, or specific names/details disclosed in the provided information. No positive or negative performance indicators, guidance changes, or market impacts are mentioned.

KROGER CO8-Kneutralmateriality 5/10

09-02-2026

Kroger Co filed an 8-K on 2026-02-09 disclosing an officer or director change under Item 5.02, which includes departures, elections, appointments, and compensatory arrangements for certain officers. The filing also contains Regulation FD disclosure under Item 7.01 and lists financial statements and exhibits under Item 9.01. No specific details on positions affected, individuals involved, reasons, or financial impacts are disclosed.

White Pearl Acquisition Corp.8-Kneutralmateriality 4/10

09-02-2026

White Pearl Acquisition Corp. filed an 8-K on 2026-02-09 disclosing Other Events under Item 8.01 and Financial Statements and Exhibits under Item 9.01. No quantitative metrics, deal terms, parties involved, financial data, or strategic details are explicitly stated in the provided filing information. Critical transaction specifics remain NOT_DISCLOSED, limiting assessment of impact.

XOMA Royalty Corp8-Kneutralmateriality 8/10

09-02-2026

XOMA Royalty Corp filed an 8-K on 2026-02-09 announcing the completion of an acquisition or disposition of assets under Item 2.01. The filing also discloses other events under Item 8.01 and provides financial statements and exhibits under Item 9.01. No specific transaction details, financial metrics, parties involved, or quantitative impacts are disclosed.

LIQUIDITY SERVICES INC8-Kneutralmateriality 3/10

09-02-2026

Liquidity Services Inc filed an 8-K on 2026-02-09 (AccNo: 0001193125-26-042756) under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names, titles, reasons for change, effective dates, or financial terms are disclosed. Sector information is not specified.

Frontier Group Holdings, Inc.8-Kneutralmateriality 4/10

09-02-2026

Frontier Group Holdings, Inc. filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals, reasons, or terms are disclosed.

Warby Parker Inc.8-Kneutralmateriality 6/10

09-02-2026

Warby Parker Inc. filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the key position, appointment/resignation status, reasons, or timing are provided. No quantitative metrics, performance comparisons, or financial data are mentioned.

BECTON DICKINSON & CO8-Kneutralmateriality 7/10

09-02-2026

Becton Dickinson & Co filed a Form 8-K on February 9, 2026, disclosing events under multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details, transaction values, financial metrics, personnel changes, or quantitative impacts are provided in the filing summary. This is a multi-item filing with no disclosed positive or negative metrics for balanced assessment.

Unknown8-Kneutralmateriality 3/10

09-02-2026

The company filed an 8-K on February 9, 2026 (AccNo: 0000022606-26-000002), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Specific details including the officer's name, key position (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, and any timing or succession information are NOT_DISCLOSED. No quantitative data, financial metrics, governance impacts, board outcomes, or scheduled events are mentioned.

EQUITY LIFESTYLE PROPERTIES INC8-Kneutralmateriality 4/10

09-02-2026

EQUITY LIFESTYLE PROPERTIES INC filed an 8-K on 2026-02-09 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers, and under Item 8.01 for other events. No specific details on affected positions, individuals involved, reasons for changes, timing, or any quantitative metrics are disclosed. No positive or negative performance metrics, scheduled events, or financial impacts are mentioned.

WATERS CORP /DE/8-Kneutralmateriality 9/10

09-02-2026

Waters Corp /DE/ filed an 8-K on February 09, 2026, announcing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), alongside creation of a direct financial obligation (Item 2.03). The filing also discloses changes in directors or officers including compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and includes financial statements and exhibits (Item 9.01). No specific transaction details, financial metrics, parties, or impacts are provided in the available filing information.

  • ·AccNo: 0001193125-26-042819
  • ·Filing Size: 3 MB
  • ·Event Type: Merger/Acquisition
TEAM INC8-Kneutralmateriality 4/10

09-02-2026

Team Inc. (TEAM) filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on the affected position, individual names, reasons for change, or any quantitative data were provided.

TREX CO INC8-Kneutralmateriality 4/10

09-02-2026

TREX CO INC filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. Specific details including the key position affected, appointment or resignation status, reasons, or timing are NOT_DISCLOSED.

Crimson Wine Group, Ltd8-Kneutralmateriality 8/10

09-02-2026

Crimson Wine Group, Ltd. filed an 8-K on 2026-02-09 disclosing entry into a material definitive agreement under Item 1.01 and completion of an acquisition or disposition of assets under Item 2.01. The filing also includes Regulation FD disclosure under Item 7.01 and financial statements and exhibits under Item 9.01. No specific deal terms, financial metrics, parties involved, or performance impacts are disclosed.

NGL Energy Partners LP8-Kneutralmateriality 4/10

09-02-2026

NGL Energy Partners LP filed an 8-K on 2026-02-09 disclosing Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 5.07 covers submission of matters to a vote of security holders, while Item 9.01 includes financial statements and exhibits. No specific details on personnel changes, vote outcomes, reasons, timing, or quantitative metrics are disclosed.

RESOURCES CONNECTION, INC.8-Kneutralmateriality 4/10

09-02-2026

Resources Connection, Inc. filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or financial metrics are disclosed.

DTE ENERGY CO8-Kneutralmateriality 4/10

09-02-2026

DTE Energy Co filed an 8-K on 2026-02-09 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any financial metrics are disclosed. No quantitative data, scheduled events, or other material developments were mentioned.

SpyGlass Pharma, Inc.8-Kneutralmateriality 5/10

09-02-2026

SpyGlass Pharma, Inc. filed an 8-K on February 9, 2026, disclosing an officer change or departure of directors under Item 5.02 (including compensatory arrangements of certain officers), amendments to articles of incorporation or bylaws under Item 5.03, and Regulation FD disclosure under Item 7.01. No specific details on positions affected, individuals involved, reasons for changes, timing, or financial impacts are disclosed. Item 9.01 references financial statements and exhibits, but contents are NOT_DISCLOSED.

AMEREN CORP8-Kneutralmateriality 5/10

09-02-2026

Ameren Corp filed an 8-K on February 9, 2026 (AccNo: 0001104659-26-012085), disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details such as the affected officer's name, position, reason for change, appointment or resignation status, and any numerical data are NOT_DISCLOSED.

TREDEGAR CORP8-Kneutralmateriality 5/10

09-02-2026

Tredegar Corp filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, and timing are NOT_DISCLOSED.

Pebblebrook Hotel Trust8-Kneutralmateriality 5/10

09-02-2026

Pebblebrook Hotel Trust filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the key position affected, appointment or resignation status, reasons for the change, timing, or any quantitative metrics are disclosed. No positive or negative performance metrics are mentioned.

HARMONIC INC.8-Kneutralmateriality 5/10

09-02-2026

Harmonic Inc. filed an 8-K on February 9, 2026 (AccNo: 0001193125-26-042914), disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits are included. No specific details on the affected officer, position, reason for change, or timing are disclosed.

Applied Digital Corp.8-Kneutralmateriality 6/10

09-02-2026

Applied Digital Corp. filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, names, reasons for changes, or any quantitative metrics are disclosed.

IDEX CORP /DE/8-Kneutralmateriality 3/10

09-02-2026

IDEX Corporation (IDEX CORP /DE/) filed an 8-K on February 9, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including key positions affected, names of individuals, reasons for changes, timing, internal/external status, or any quantitative data are disclosed. This appears to be a routine governance filing with no additional financial or operational metrics provided.

  • ·AccNo: 0001193125-26-042918
  • ·Filing size: 133 KB
  • ·Event date: February 09, 2026
  • ·Sector: not specified
CION Investment Corp8-Kneutralmateriality 7/10

09-02-2026

CION Investment Corp filed an 8-K on 2026-02-09 disclosing entry into a Material Definitive Agreement under Item 1.01, with Financial Statements and Exhibits attached under Item 9.01. No specific details on the agreement, transaction value, financial impacts, or quantitative metrics are provided. Sector is not specified.

GLACIER BANCORP, INC.8-Kneutralmateriality 5/10

09-02-2026

Glacier Bancorp, Inc. filed an 8-K on February 9, 2026 (AccNo: 0000868671-26-000009, Size: 509 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the officer involved, position affected, appointment or resignation status, reason for change, effective date, or any compensatory arrangements are disclosed. No quantitative financial metrics, period-over-period comparisons, scheduled events, or other numerical data are mentioned.

FIVE BELOW, INC8-Kneutralmateriality 5/10

09-02-2026

Five Below, Inc. filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the affected position, individual involved, reason for change, or timing are disclosed.

Planet Fitness, Inc.8-Kneutralmateriality 4/10

09-02-2026

Planet Fitness, Inc. filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the key position affected, appointment or resignation status, reasons for change, named individuals, or any quantitative terms were disclosed. This appears to be an informational filing with no financial metrics, performance comparisons, or directional implications provided.

Cyngn Inc.8-Kneutralmateriality 5/10

09-02-2026

Cyngn Inc. filed an 8-K on 2026-02-09 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific positions affected, names, reasons, timing, or quantitative details such as compensation amounts are mentioned. No financial metrics, positive or negative changes, or performance comparisons are reported.

  • ·AccNo: 0001213900-26-013688
  • ·File size: 189 KB
  • ·Sector: not specified
  • ·Critical missing information: officer names, titles (e.g., CEO/CFO), action (appointment/resignation), effective dates, reasons for change, compensation details, board composition impact
Pebblebrook Hotel Trust8-Kneutralmateriality 4/10

09-02-2026

Pebblebrook Hotel Trust filed an 8-K on February 9, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific names, positions, reasons for changes, numerical data, or further details are disclosed.

New America Acquisition I Corp.8-Kneutralmateriality 3/10

09-02-2026

New America Acquisition I Corp. filed an 8-K on 2026-02-09 under Item 5.02 regarding departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details, names, dates, financial metrics, or merger/acquisition transaction information are explicitly stated in the provided filing summary. No quantitative data or period-over-period comparisons are disclosed.

Streamex Corp.8-Kneutralmateriality 3/10

09-02-2026

Streamex Corp. filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with other events in Item 8.01 and financial statements/exhibits in Item 9.01. No specific details on the key position affected, appointment or resignation status, reasons for the change, timing, or any quantitative data are disclosed in the provided filing information.

Generation Bio Co.8-Kmixedmateriality 10/10

09-02-2026

Generation Bio Co. announced the completion of an acquisition or disposition of assets (Item 2.01) and a change in control of the registrant (Item 5.01), alongside entry into a new material definitive agreement (Item 1.01). However, the filing also discloses termination of a prior material definitive agreement (Item 1.02), notice of delisting or failure to satisfy listing standards (Item 3.01), and material modifications to rights of security holders (Item 3.03), signaling potential loss of public market access. Governance changes include departures or elections of directors/officers (Item 5.02) and amendments to articles of incorporation or bylaws (Item 5.03).

UnknownAdministrationbearishmateriality 10/10

09-02-2026

Company entered Administration on February 09, 2026, signaling financial distress under Part 5.3A of the Corporations Act 2001 (Cth), likely voluntary administration process managed by an appointed administrator. The announcement also discloses the retirement of the Chief Information Officer, a non-financial event with no disclosed implications for restructuring. Critical details including debt obligations, asset values, creditor hierarchy (secured vs unsecured under s 561), recovery prospects (cents per dollar), timeline expectations, going concern viability, employee entitlements, director liability, and ASIC investigation risks are NOT_DISCLOSED, preventing detailed stakeholder impact assessment.

Tivic Health Systems, Inc.8-Kneutralmateriality 8/10

09-02-2026

Tivic Health Systems, Inc. filed a Form 8-K on 2026-02-09 reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, accompanied by financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details on the agreement terms, transaction size, parties, or financial impacts disclosed in the provided information. No quantitative metrics, positive or negative changes, or performance comparisons are mentioned.

REGIONS FINANCIAL CORP8-K/Aneutralmateriality 3/10

09-02-2026

Regions Financial Corp filed an 8-K on 2026-02-09 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions, names, reasons, or impacts are disclosed.

Gold.com, Inc.8-Kneutralmateriality 8/10

09-02-2026

Gold.com, Inc. filed an 8-K on February 9, 2026, reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. This is a multi-item mandatory disclosure with no specific details provided on the agreement's nature, parties, terms, value, or financial impacts. No quantitative metrics, positive or negative changes, or operational effects are disclosed.

RADIAN GROUP INC8-Kneutralmateriality 5/10

09-02-2026

Radian Group Inc filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. The filing also includes Regulation FD Disclosure under Item 7.01 and financial statements and exhibits under Item 9.01. No specific details on the officer involved, reason for change, timing, or any quantitative impacts are disclosed.

PINTEREST, INC.8-Kneutralmateriality 6/10

09-02-2026

Pinterest, Inc. filed an 8-K on February 9, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, or any named individuals are NOT_DISCLOSED. No quantitative data, financial metrics, or performance comparisons are mentioned in the provided filing information.

F&M BANK CORP8-Kneutralmateriality 3/10

09-02-2026

F&M Bank Corp filed an 8-K on February 9, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on key positions affected, individuals involved, reasons for the change, timing, or any quantitative impacts are disclosed. No positive or negative metrics, financial data, or performance comparisons are mentioned in the provided information.

CURIS INC8-Kbearishmateriality 10/10

09-02-2026

Curis Inc filed a Form 8-K on 2026-02-09 under Item 3.01, providing Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No financial metrics, transaction values, reasons for delisting, or timelines were disclosed. This is a material negative event signaling potential loss of exchange listing status.

Playboy, Inc.8-Kneutralmateriality 8/10

09-02-2026

Playboy, Inc. filed an 8-K on 2026-02-09 disclosing entry into a material definitive agreement under Item 1.01 and Regulation FD disclosure under Item 7.01, with financial statements and exhibits attached under Item 9.01. No specific details on the agreement, transaction value, financial metrics, positive or negative impacts, or performance comparisons were provided in the filing summary.

UPEXI, INC.8-Kneutralmateriality 8/10

09-02-2026

UPEXI, INC. filed an 8-K on 2026-02-09 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, events, or exhibits provided in the summary. No financial metrics, transaction values, or performance comparisons are disclosed.

Fifth District Bancorp, Inc.8-Kneutralmateriality 5/10

09-02-2026

Fifth District Bancorp, Inc. filed a Form 8-K on 2026-02-09 disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer position, appointment or resignation status, reasons for change, financial metrics, or other quantitative data are disclosed. No positive or negative metrics are present to balance.

Once Upon a Farm, PBC8-Kneutralmateriality 8/10

09-02-2026

Once Upon a Farm, PBC filed a Form 8-K on February 9, 2026 (AccNo: 0001193125-26-042994) reporting multiple events: entry into a material definitive agreement (Item 1.01), material modifications to rights of security holders (Item 3.03), departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements (Item 5.02), and amendments to articles of incorporation or bylaws (Item 5.03), along with financial statements and exhibits (Item 9.01). This multi-item filing signals significant governance and contractual changes, but no specific transaction details, financial impacts, or quantitative metrics are disclosed.

CEA Industries Inc.8-Kneutralmateriality 4/10

09-02-2026

CEA Industries Inc. filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the affected position, appointment or resignation, reasons, or any financial metrics are NOT_DISCLOSED.

SPACSphere Acquisition Corp.8-Kneutralmateriality 8/10

09-02-2026

SPACSphere Acquisition Corp. filed an 8-K on February 09, 2026, under Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits), signaling a merger or acquisition event typical for a SPAC. No quantitative metrics, deal terms, parties beyond the filer, valuations, synergies, or timelines are disclosed. No positive or negative financial changes are mentioned.

Seaport Entertainment Group Inc.8-Kneutralmateriality 8/10

09-02-2026

Seaport Entertainment Group Inc. filed an 8-K on 2026-02-09 disclosing the completion of an acquisition or disposition of assets under Item 2.01. The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No quantitative details, parties involved, strategic rationale, or financial impacts were disclosed.

VOLITIONRX LTD8-Kbearishmateriality 10/10

09-02-2026

VolitionRx Ltd filed an 8-K on February 9, 2026 (AccNo: 0001477932-26-000714), reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, which is a material negative event signaling potential compliance or financial issues. Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits) were also included, but no specific financial metrics, positive developments, or quantitative details were disclosed. No positive or flat metrics were mentioned to offset the delisting notice.

Greenlane Holdings, Inc.8-Kneutralmateriality 8/10

09-02-2026

Greenlane Holdings, Inc. filed a Form 8-K on 2026-02-09 reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No details on the agreement, transaction value, financial impacts, or other metrics are disclosed in the provided filing summary. This is a multi-item mandatory disclosure filed on the event date.

K2 Capital Acquisition Corp8-K/Aneutralmateriality 5/10

09-02-2026

K2 Capital Acquisition Corp filed an 8-K on 2026-02-09 (AccNo: 0001213900-26-013760, Size: 402 KB) under Item 9.01 disclosing Financial Statements and Exhibits in connection with a Merger/Acquisition event. No specific details on deal structure, parties involved beyond the filer, valuation, financial metrics, or performance comparisons are explicitly stated in the filing summary. Sector is not specified, and no positive or negative metrics are provided.

Wellgistics Health, Inc.8-Kneutralmateriality 5/10

09-02-2026

Wellgistics Health, Inc. filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, appointment or resignation, reasons, or timing are disclosed. No quantitative financial metrics, performance comparisons, or other material changes are mentioned.

374Water Inc.8-Kbearishmateriality 9/10

09-02-2026

374Water Inc. filed a multi-item Form 8-K on February 9, 2026, reporting entry into a material definitive agreement (Item 1.01), notice of delisting or failure to satisfy a continued listing rule or standard (Item 3.01), and departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements (Item 5.02), along with financial statements and exhibits (Item 9.01). The delisting notice signals significant compliance issues with exchange listing standards, which is typically negative, while the material agreement and officer changes lack disclosed details that could imply strategic shifts but carry uncertainty. No financial metrics, transaction values, or quantitative impacts were disclosed.

GigCapital9 Corp.8-Kneutralmateriality 5/10

09-02-2026

GigCapital9 Corp. filed an 8-K on February 9, 2026 (AccNo: 0001193125-26-043037), under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for changes, or impacts are provided. No quantitative financial metrics, performance comparisons, or other corporate actions are mentioned.

Clear Channel Outdoor Holdings, Inc.8-Kneutralmateriality 8/10

09-02-2026

Clear Channel Outdoor Holdings, Inc. filed a Form 8-K on February 9, 2026 (AccNo: 0001193125-26-043066), reporting under multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing for key events like material agreements and officer changes, but no specific transaction details, financial metrics, named parties, dollar values, or quantitative impacts are disclosed in the provided information. No positive, negative, or flat performance metrics are mentioned.

Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 120 filings

🇺🇸 More from United States

View all →